The vision, journey, and mission driving Bio-Stride's innovation in emergency diagnostics
Founder & CEO, Bio-Stride
A dual-degree holder in Electronics Engineering and Biological Sciences from BITS Pilani, Anagh combines deep technical expertise with personal conviction. His journey from a small town in Rajasthan to leading research at the University of Tokyo and ETH Zurich reflects an unwavering commitment to solving healthcare's most pressing challenges.
Driven by personal experiences with family members affected by delayed TBI diagnosis, Anagh founded Bio-Stride to ensure that geography and infrastructure never determine healthcare outcomes. His vision: democratize access to life-saving diagnostics across India's 1.4 billion population.
"Every life lost to delayed diagnosis is a family shattered, a future erased. I've seen this tragedy three times in my own family. Bio-Stride exists because no one should lose their independence, their abilities, or their life simply because they couldn't access a CT scan in time. This isn't just a companyβit's a promise to the 93% of Indians who lack adequate emergency diagnostics."
β Anagh Sinha, Founder & CEO
Recognized by the Institute of International Education for innovative approaches to global health challenges, specifically for early diagnostic system design.
One of the most prestigious biotechnology research fellowships globally, awarded to less than 1% of applicants for exceptional research potential.
2024 Best Poster Presentation Award at the University of Tokyo International Conference for diagnostic systems research.
Filed patent for "Portable Point-of-Care Diagnostic System for Early Detection of Traumatic Brain Injury using Blood Biomarkers."
Successfully built and exited two startups (Oxon and DermaGlow) while pursuing undergraduate studies, impacting 2M+ lives.
Dual degree holder from BITS Pilani, accepted at MIT-Harvard Joint Laboratory (visa constraints), research positions at world's top institutions.